Novo Nordisk's obesity pill shows cardiovascular benefits, comparable efficacy to injection

Pedersen COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss ...
Fierce Healthcare

Hims & Hers in talks with Novo Nordisk to sell Wegovy injections, new obesity pill

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Trump administration nearing deals with drugmakers on discounted weight loss medications: report

The Trump administration plans to announce a deal with pharmaceutical companies to sell discounted weight-loss drugs through ...
Morningstar

Novo Nordisk Says Wegovy Weight-Loss Pill Matches Shot as it Eyes Landmark Approval

Novo Nordisk's experimental daily Wegovy pill helped patients lose about as much weight as its weekly injection, according to data from a late-stage trial. The pill has already been sent ...
NBC Washington

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%

Shares of Hims & Hers closed up 23% on Tuesday, while Novo Nordisk's stock closed up 4%. The Danish drugmaker is racing to capture more patients now that many compounding pharmacies are legally ...

Hims & Hers Health in discussions with Novo Nordisk to sell Wegovy

In June, Novo ended a partnership with Hims & Hers that provided access to Wegovy through the pharma's Novocare Pharmacy because Hims & Hers was trying to skirt legal restrictions on compounding ...

Novo Nordisk cuts sales and profits guidance amid obesity drug competition

The boss of the Wegovy firm linked its reduced guidance to the market for weight-loss treatments being ‘more competitive than ...